Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kumar Prabhash

Showing results (421-430 of 469) with videos related to

Pageof 47
Sort By:
Ecancermedicalscience|December 21, 2016
Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, MumbaiPan Pantziarka, Lisa Hutchinson, Nicolas André, et al.
Cancer Medicine|September 29, 2018
Analysis of solid tumor mutation profiles in liquid biopsySai A Balaji, Ashwini Shanmugam, Anuradha Chougule, et al.
International Journal of Cancer|November 9, 2021
The clinical utility and safety of short-course immune checkpoint inhibitors in multiple tumours-A real-world multicentric study from IndiaGeorge Abraham, Vanita Noronha, Senthil Rajappa, et al.
International Journal of Cancer|October 11, 2018
ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancerPrajish Iyer, Shailesh V Shrikhande, Malika Ranjan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2025
Presentation and outcomes of second primary malignancies (SPMs) in locally advanced oral cavity squamous carcinoma (LA-OSCC): Secondary analysis of a phase III randomised control trial (NCT00193843)Sarbani Ghosh Laskar, Sahil Sood, Abhishek Chatterjee, et al.
JCO Global Oncology|March 11, 2026
Carica Papaya Leaf Extract to Improve Chemotherapy-Induced Thrombocytopenia: A Phase III Triple-Blinded, Randomized, Placebo-Controlled, Multicentric TrialVikas Ostwal, Manali Parulekar, Deepali Naughane, et al.
Head & Neck|March 9, 2021
Intensity-modulated radiation therapy for nasal cavity and paranasal sinus tumors: Experience from a single instituteSarbani Ghosh Laskar, Prathamesh Pai, Shwetabh Sinha, et al.
Indian Journal of Cancer|March 9, 2026
Cetuximab in platinum-ineligible patients with locally advanced squamous cell carcinoma of the head and neck: Consensus from IndiaAgarwala Vivek, Aggarwal Shyam, Agrawal Shyam, et al.
JAMA|March 13, 2025
Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical TrialRobert Haddad, Jérôme Fayette, Maria Teixeira, et al.
South Asian Journal of Cancer|December 22, 2025
Patterns of Failure in Head and Neck Carcinoma of Unknown Primary: Insights from a Tobacco-Associated Cancer CohortSarbani Ghosh Laskar, Jifmi Jose Manjali, Ashwini Budrukkar, et al.
Pageof 47

Showing results (421-430 of 469) with videos related to

Sort By:
Pageof 47
Ecancermedicalscience|December 21, 2016
Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, MumbaiPan Pantziarka, Lisa Hutchinson, Nicolas André, et al.
Cancer Medicine|September 29, 2018
Analysis of solid tumor mutation profiles in liquid biopsySai A Balaji, Ashwini Shanmugam, Anuradha Chougule, et al.
International Journal of Cancer|November 9, 2021
The clinical utility and safety of short-course immune checkpoint inhibitors in multiple tumours-A real-world multicentric study from IndiaGeorge Abraham, Vanita Noronha, Senthil Rajappa, et al.
International Journal of Cancer|October 11, 2018
ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancerPrajish Iyer, Shailesh V Shrikhande, Malika Ranjan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2025
Presentation and outcomes of second primary malignancies (SPMs) in locally advanced oral cavity squamous carcinoma (LA-OSCC): Secondary analysis of a phase III randomised control trial (NCT00193843)Sarbani Ghosh Laskar, Sahil Sood, Abhishek Chatterjee, et al.
JCO Global Oncology|March 11, 2026
Carica Papaya Leaf Extract to Improve Chemotherapy-Induced Thrombocytopenia: A Phase III Triple-Blinded, Randomized, Placebo-Controlled, Multicentric TrialVikas Ostwal, Manali Parulekar, Deepali Naughane, et al.
Head & Neck|March 9, 2021
Intensity-modulated radiation therapy for nasal cavity and paranasal sinus tumors: Experience from a single instituteSarbani Ghosh Laskar, Prathamesh Pai, Shwetabh Sinha, et al.
Indian Journal of Cancer|March 9, 2026
Cetuximab in platinum-ineligible patients with locally advanced squamous cell carcinoma of the head and neck: Consensus from IndiaAgarwala Vivek, Aggarwal Shyam, Agrawal Shyam, et al.
JAMA|March 13, 2025
Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical TrialRobert Haddad, Jérôme Fayette, Maria Teixeira, et al.
South Asian Journal of Cancer|December 22, 2025
Patterns of Failure in Head and Neck Carcinoma of Unknown Primary: Insights from a Tobacco-Associated Cancer CohortSarbani Ghosh Laskar, Jifmi Jose Manjali, Ashwini Budrukkar, et al.
Pageof 47